Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
| Prif Awduron: | , , , , , , , , , |
|---|---|
| Fformat: | Journal article |
| Cyhoeddwyd: |
2000
|
| _version_ | 1826274507301584896 |
|---|---|
| author | Croucher, P Shipman, C Perry, M Lippitt, J Asosingh, K van Beek, E Van Camp, B Russell, G Dunstan, C Vanderkerken, K |
| author_facet | Croucher, P Shipman, C Perry, M Lippitt, J Asosingh, K van Beek, E Van Camp, B Russell, G Dunstan, C Vanderkerken, K |
| author_sort | Croucher, P |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T22:44:28Z |
| format | Journal article |
| id | oxford-uuid:5cae4070-9b75-41c6-bef0-207370016274 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T22:44:28Z |
| publishDate | 2000 |
| record_format | dspace |
| spelling | oxford-uuid:5cae4070-9b75-41c6-bef0-2073700162742022-03-26T17:29:46ZOsteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5cae4070-9b75-41c6-bef0-207370016274Symplectic Elements at Oxford2000Croucher, PShipman, CPerry, MLippitt, JAsosingh, Kvan Beek, EVan Camp, BRussell, GDunstan, CVanderkerken, K |
| spellingShingle | Croucher, P Shipman, C Perry, M Lippitt, J Asosingh, K van Beek, E Van Camp, B Russell, G Dunstan, C Vanderkerken, K Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma. |
| title | Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma. |
| title_full | Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma. |
| title_fullStr | Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma. |
| title_full_unstemmed | Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma. |
| title_short | Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma. |
| title_sort | osteoprotegerin opg inhibits the development of osteolytic bone disease in the 5t2mm model of multiple myeloma |
| work_keys_str_mv | AT croucherp osteoprotegerinopginhibitsthedevelopmentofosteolyticbonediseaseinthe5t2mmmodelofmultiplemyeloma AT shipmanc osteoprotegerinopginhibitsthedevelopmentofosteolyticbonediseaseinthe5t2mmmodelofmultiplemyeloma AT perrym osteoprotegerinopginhibitsthedevelopmentofosteolyticbonediseaseinthe5t2mmmodelofmultiplemyeloma AT lippittj osteoprotegerinopginhibitsthedevelopmentofosteolyticbonediseaseinthe5t2mmmodelofmultiplemyeloma AT asosinghk osteoprotegerinopginhibitsthedevelopmentofosteolyticbonediseaseinthe5t2mmmodelofmultiplemyeloma AT vanbeeke osteoprotegerinopginhibitsthedevelopmentofosteolyticbonediseaseinthe5t2mmmodelofmultiplemyeloma AT vancampb osteoprotegerinopginhibitsthedevelopmentofosteolyticbonediseaseinthe5t2mmmodelofmultiplemyeloma AT russellg osteoprotegerinopginhibitsthedevelopmentofosteolyticbonediseaseinthe5t2mmmodelofmultiplemyeloma AT dunstanc osteoprotegerinopginhibitsthedevelopmentofosteolyticbonediseaseinthe5t2mmmodelofmultiplemyeloma AT vanderkerkenk osteoprotegerinopginhibitsthedevelopmentofosteolyticbonediseaseinthe5t2mmmodelofmultiplemyeloma |